<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1028-4818</journal-id>
<journal-title><![CDATA[Multimed]]></journal-title>
<abbrev-journal-title><![CDATA[Multimed]]></abbrev-journal-title>
<issn>1028-4818</issn>
<publisher>
<publisher-name><![CDATA[Centro Provincial de Información de Ciencias Médicas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1028-48182022000100010</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Factores de riesgo de las enfermedades cardiovasculares en pacientes mayores de 18 años]]></article-title>
<article-title xml:lang="en"><![CDATA[Risk factors for cardiovascular diseases in patients older than 18 years]]></article-title>
<article-title xml:lang="pt"><![CDATA[Fatores de risco para doenças cardiovasculares em pacientes maiores de 18 anos]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Lago Santiesteban]]></surname>
<given-names><![CDATA[Yasel Alberto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Labrada Tapia]]></surname>
<given-names><![CDATA[Domingo Ángel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Breijo Puentes]]></surname>
<given-names><![CDATA[Alina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Lago Santiesteban]]></surname>
<given-names><![CDATA[Diana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sosa García]]></surname>
<given-names><![CDATA[Daniel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Ciencias Médicas Granma Hospital General Universitario Carlos Manuel de Céspedes ]]></institution>
<addr-line><![CDATA[Bayamo Granma]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>02</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>02</month>
<year>2022</year>
</pub-date>
<volume>26</volume>
<numero>1</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1028-48182022000100010&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1028-48182022000100010&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1028-48182022000100010&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción:  las enfermedades cardiovasculares son la principal causa de morbilidad y mortalidad, a pesar de las mejoras en los resultados clínicos y la introducción de nuevos fármacos.  Objetivo:  evaluar la influencia de factores riesgo en el desarrollo de enfermedades cardiovasculares en el adulto de 18 años o más.  Método:  se realizó un estudio retrospectivo de casos y testigos en pacientes con el diagnóstico de enfermedad cardiovascular que acuden al servicio de medicina interna del Hospital General Universitario &#8220;Carlos Manuel de Céspedes&#8221;, Bayamo, Granma, desde el 5 de enero de 2017 hasta el 31 de diciembre de 2018. Dentro de los factores de riesgo se tuvo en cuenta la edad, género, comorbilidad y los marcadores biológicos.  Resultados:  dentro de las variables cualitativas el hábito de fumar fue el factor más importante (OR: 3,60; IC: 1,664-7,787; p: 0,001) mientras que de las cuantitativas fue la hipertensión sistólica (OR: 11,50; IC: 1,457-90,896; p: 0,004). El análisis multivariado, mostró que la hipertensión sistólica fue el factor de riesgo independiente más relevante (OR: 11,52; IC del 95%: 3,077- 43,168; p: 0,000) seguido tener como antecedentes de diabetes mellitus (OR: 5,91; IC del 95%: 1,674-20,910).  Conclusiones:  sobresale como factor de riesgo independiente más importante la hipertensión sistólica, seguida de padecer de diabetes mellitus y tener edad igual o superior a 60 años.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction: cardiovascular diseases are the main cause of morbidity and mortality, despite improvements in clinical results and the introduction of new drugs.  Objective:  to evaluate the influence of risk factors in the development of cardiovascular diseases in adults aged 18 years or older.  Method: a retrospective study of cases and controls was carried out in patients diagnosed with cardiovascular disease who attend the internal medicine service of the General University Hospital "Carlos Manuel de Céspedes," Bayamo, Granma, from January 5, 2017 to December 31, 2018. Within the risk factors, age, gender, comorbidity and biological markers were taken into account.  Results: among the qualitative variables, smoking was the most important factor (OR: 3.60; CI: 1.664-7.787; p: 0.001) while among the quantitative variables it was systolic hypertension (OR: 11.50; CI: 1457-90896, p: 0.004). Multivariate analysis showed that systolic hypertension was the most relevant independent risk factor (OR: 11.52; 95% CI: 3.077-43.168; p: 0.000) followed by having a history of diabetes mellitus (OR: 5.91 ;95% CI: 1674-20910).  Conclusions:  systolic hypertension stands out as the most important independent risk factor, followed by suffering from diabetes mellitus and being 60 years of age or older.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[RESUMO  Introdução:  as doenças cardiovasculares são a principal causa de morbimortalidade, apesar da melhora nos resultados clínicos e da introdução de novos medicamentos.  Objetivo: avaliar a influência dos fatores de risco no desenvolvimento de doenças cardiovasculares em adultos com 18 anos ou mais.  Método: foi realizado um estudo retrospectivo de casos e controles em pacientes diagnosticados com doenças cardiovasculares que frequentam o serviço de medicina interna do Hospital Geral Universitário "Carlos Manuel de Céspedes", Bayamo, Granma, de 5 de janeiro de 2017 a 31 de dezembro de 2018 Dentro dos fatores de risco foram considerados idade, sexo, comorbidade e marcadores biológicos.  Resultados:  entre as variáveis &#8203;&#8203;qualitativas, o tabagismo foi o fator mais importante (OR: 3,60; IC: 1,664-7,787; p: 0,001) enquanto entre as variáveis &#8203;&#8203;quantitativas foi a hipertensão sistólica (OR: 11,50; IC: 1457-90896, p: 0,004). A análise multivariada mostrou que a hipertensão sistólica foi o fator de risco independente mais relevante (OR: 11,52; IC 95%: 3,077-43,168; p: 0,000) seguido por história de diabetes mellitus (OR: 5,91; IC 95%: 1674-20910 ).  Conclusões:  a hipertensão sistólica destaca-se como o fator de risco independente mais importante, seguido por diabetes mellitus e idade igual ou superior a 60 anos.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Enfermedad cerebrovascular]]></kwd>
<kwd lng="es"><![CDATA[Factores de riesgo, Hipertensión sistólica]]></kwd>
<kwd lng="en"><![CDATA[Cerebrovascular disease]]></kwd>
<kwd lng="en"><![CDATA[Risk factors, Systolic hypertension]]></kwd>
<kwd lng="pt"><![CDATA[Doença cerebrovascular]]></kwd>
<kwd lng="pt"><![CDATA[Fatores de risco, Hipertensão sistólica]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Benavides Bautista]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez Villacis]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Álvarez]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Manzano]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Zambrano]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnóstico, imagenología y accidente cerebrovascular]]></article-title>
<source><![CDATA[Enferm Inv (Ambato)]]></source>
<year>2018</year>
<volume>3</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>77-83</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García Alfonso]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez Reyes]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Ricaurte Fajardo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Coral]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Actualización en diagnóstico y tratamiento del ataque cerebrovascular isquémico agudo.]]></article-title>
<source><![CDATA[Univ. Med]]></source>
<year>2019</year>
<volume>60</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>1-17</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Piepoli]]></surname>
<given-names><![CDATA[MF]]></given-names>
</name>
<name>
<surname><![CDATA[Hoes]]></surname>
<given-names><![CDATA[AW]]></given-names>
</name>
<name>
<surname><![CDATA[Agewall]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Albus]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Brotons]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Catapano]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guía ESC 2016 sobre prevención de la enfermedad cardiovascular en la práctica clínica]]></article-title>
<source><![CDATA[Rev Esp Cardiol]]></source>
<year>2016</year>
<volume>69</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>939.e1-939.e87</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Álvarez Aliaga]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[González Aguilera]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Maceo Gómez]]></surname>
<given-names><![CDATA[LR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factors associated to hypertensive heart disease development: a prospective cohort study in Bayamo, Cuba]]></article-title>
<source><![CDATA[Medwave]]></source>
<year>2016</year>
<volume>16</volume>
<numero>6</numero>
<issue>6</issue>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Powers]]></surname>
<given-names><![CDATA[WJ]]></given-names>
</name>
<name>
<surname><![CDATA[Rabinstein]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
<name>
<surname><![CDATA[Ackerson]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Adeoye]]></surname>
<given-names><![CDATA[OM]]></given-names>
</name>
<name>
<surname><![CDATA[Bambakidis]]></surname>
<given-names><![CDATA[NC]]></given-names>
</name>
<name>
<surname><![CDATA[Becker]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Health care Professionals Fromthe American Heart Association/American Stroke Association]]></article-title>
<source><![CDATA[Stroke]]></source>
<year>2018</year>
<volume>49</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>e46-9</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García Jurado]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Roldán Romero]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez Montilla]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Valverde Moyano]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Bravo Rey]]></surname>
<given-names><![CDATA[IM]]></given-names>
</name>
<name>
<surname><![CDATA[Delgado Acosta]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Incidencia, pronóstico y predicción de la transformación hemorrágica tras el tratamiento revascularizador del ictus]]></article-title>
<source><![CDATA[Neurología]]></source>
<year>2021</year>
<volume>36</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>589-96</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Whelton]]></surname>
<given-names><![CDATA[PK]]></given-names>
</name>
<name>
<surname><![CDATA[Carey]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Aronow]]></surname>
<given-names><![CDATA[WS]]></given-names>
</name>
<name>
<surname><![CDATA[Casey]]></surname>
<given-names><![CDATA[DE]]></given-names>
</name>
<name>
<surname><![CDATA[Collins]]></surname>
<given-names><![CDATA[KJ]]></given-names>
</name>
<name>
<surname><![CDATA[Himmelfarb]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines]]></article-title>
<source><![CDATA[Hypertension]]></source>
<year>2018</year>
<volume>71</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>e13-e115</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gállego Culleré]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Protocolo de tratamiento del ictus isquémico en fase aguda]]></article-title>
<source><![CDATA[Medicine]]></source>
<year>2019</year>
<volume>12</volume>
<numero>70</numero>
<issue>70</issue>
<page-range>4130-7</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sequeira Quesada]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Villegas Reyes]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Actualidad en el uso de la terapia dual en antiagregación plaquetaria con aspirina y clopidogrel en el manejo agudo de enfermedad cerebrovascular]]></article-title>
<source><![CDATA[Revista Clínica de la Escuela de Medicina UCR-HRjD]]></source>
<year>2017</year>
<volume>7</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>11-21</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Izcovich]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Caruso]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Tisi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bottaro]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Pollán]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Saavedra]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Doble terapia antiagregante en pacientes con accidente cerebrovascular isquémico agudo. Recomendaciones del grupo CIERTO]]></article-title>
<source><![CDATA[Medicina (Buenos Aires)]]></source>
<year>2019</year>
<volume>79</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>315-21</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<collab>Organización Panamericana de la Salud</collab>
<article-title xml:lang=""><![CDATA[Perfil de Salud-Costa Rica]]></article-title>
<source><![CDATA[OPS]]></source>
<year>2007</year>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
